Advertisement
Canada markets closed
  • S&P/TSX

    21,554.86
    -26.44 (-0.12%)
     
  • S&P 500

    5,464.62
    -8.55 (-0.16%)
     
  • DOW

    39,150.33
    +15.53 (+0.04%)
     
  • CAD/USD

    0.7304
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    80.59
    -0.14 (-0.17%)
     
  • Bitcoin CAD

    87,749.82
    -224.73 (-0.26%)
     
  • CMC Crypto 200

    1,321.79
    -38.54 (-2.83%)
     
  • GOLD FUTURES

    2,334.70
    +3.50 (+0.15%)
     
  • RUSSELL 2000

    2,022.03
    +4.64 (+0.23%)
     
  • 10-Yr Bond

    4.2570
    +0.0030 (+0.07%)
     
  • NASDAQ

    17,689.36
    -32.24 (-0.18%)
     
  • VOLATILITY

    13.20
    -0.08 (-0.60%)
     
  • FTSE

    8,237.72
    -34.74 (-0.42%)
     
  • NIKKEI 225

    38,596.47
    -36.53 (-0.09%)
     
  • CAD/EUR

    0.6828
    +0.0007 (+0.10%)
     

Elekta shares slump after weaker-than-anticipated fourth-quarter earnings

Investing.com -- Stockholm-listed shares in Elekta (ST:EKTAb) dropped to bottom of the pan-European Stoxx 600 on Wednesday after the Swedish radiation therapy group reported a fall in fourth-quarter profit that was larger than anticipated.

Adjusted earnings before interest and taxes during the three-month period slumped by 22% to SEK 651 million, missing JPMorgan estimates cited by Reuters.

In a statement, Chief Executive Gustaf Salford said the company had faced "challenging market conditions" during the quarter that impacted its returns.

Analysts at Jefferies said that inflationary pressures, along with weakness in its Americas and Europe, Middle East, and Africa regions, dented the results.

ADVERTISEMENT

Should the losses hold, Elekta's stock is on track for its worst day since 2019.

Related Articles

Elekta shares slump after weaker-than-anticipated fourth-quarter earnings

Campbell Soup shares up on better-than-expected Q3 results

Earnings call: Guidewire's Q3 results show robust cloud deal growth